The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
32
Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors.EBI
University of Texas Medical Branch
36
Structure-Activity Relationship Studies of Substituted 2-(Isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl Cyanide Analogues: Identification of Potent Exchange Proteins Directly Activated by cAMP (EPAC) Antagonists.EBI
University of Texas Medical Branch
7
Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC).EBI
University of Texas Medical Branch
34
Identification and characterization of small molecules as potent and specific EPAC2 antagonists.EBI
University of Texas Medical Branch
19
5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP.EBI
University of Texas Medical Branch
5
Chemical synthesis and biological activity of novel brominated 7-deazaadenosine-3',5'-cyclic monophosphate derivatives.EBI
University Hospital Jena
24
Structure-activity relationships of 2-substituted phenyl-N-phenyl-2-oxoacetohydrazonoyl cyanides as novel antagonists of exchange proteins directly activated by cAMP (EPACs).EBI
University of Texas Medical Branch
5
Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets.EBI
University of Texas Medical Branch
4
Structure-Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors.EBI
Institute For Research In Cancer and Allied Diseases
31
Identification of novel 2-(benzo[d]isoxazol-3-yl)-2-oxo-N-phenylacetohydrazonoyl cyanide analoguesas potent EPAC antagonists.EBI
University of Texas Medical Branch
50
Inhibitors of hepatitis C virus replicationBDB
Merck Sharp & Dohme